Clarivate completes sale of Life Sciences & Healthcare unit to Altaris for $600 million
CLVT•Clarivate completed the sale of its Life Sciences & Healthcare segment to Altaris for $600 million. It plans to use the proceeds to reduce debt and will update its 2026 guidance with third-quarter results on Nov. 3.
1. Sale completed
Clarivate completed the $600 million sale of its Life Sciences & Healthcare segment to Altaris, a transaction previously announced July 6, 2026. The divestiture leaves Clarivate focused on its Academia & Government and Intellectual Property segments; proceeds are earmarked for debt reduction, strengthening the balance sheet and improving financial flexibility. The company plans to update its full-year 2026 guidance when it releases third-quarter results on Nov. 3, 2026.
